Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma

Clinical trial NCT00268203 · COMPLETED

Trial details

NCT number: NCT00268203
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 1998-09-01
Primary completion: 2000-03-01
Enrollment: 765

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.